CSIMarket
 

Veradigm Inc   (MDRX)

Veradigm Inc 's

Competitiveness




 

MDRX Sales vs. its Competitors Q4 2024



Comparing the current results to its competitors, Veradigm Inc reported Revenue decrease in the 4 quarter 2024 year on year by -3.72 %, despite the revenue increase by the most of its competitors of 4.28 %, recorded in the same quarter.

List of MDRX Competitors





Revenue Growth Comparisons




Net Income Comparison


Veradigm Inc , slower than the average decrease reported by the company's competitors of -23.63 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -23.63 %

<<  MDRX Stock Performance Comparisons


Veradigm Inc 's Comment on Competition and Industry Peers


The markets for our solutions and services are highly competitive, and are characterized by rapidly evolving technology and solution standards and user needs, as well as frequent introduction of new solutions and services. Some of our competitors may be more established, benefit from greater name recognition, and have substantially greater financial, technical, and marketing resources than we do.

Additionally, many of our prospective clients have invested substantial personnel and financial resources to implement and integrate competing solutions to ours. As a consequence, they may be reluctant or unwilling to migrate to our solutions. Third-party developers may be reluctant to build application services on our platform since they have invested in other competing technology platforms.

We compete primarily with numerous types of organizations, including developers of revenue cycle and practice management software and services, large system integrators, IT service providers, ambulatory and acute care EHR solutions, population health management and value-based care technologies, analytics systems, care management solutions and post-acute solutions. We generally compete on the basis of several factors, including breadth and depth of services (including our open architecture and the level of solution integration across care settings), integrated platform, regulatory compliance, reputation, reliability, accuracy, security, client service, total cost of ownership, innovation and industry acceptance, expertise and experience.

Moreover, we expect that competition will continue to increase as a result of consolidation in both the IT and healthcare industries. If one or more of our competitors or potential competitors were to merge or partner with another of our competitors, the change in the competitive landscape could adversely affect our ability to compete effectively.

Our principal existing competitors in these markets include, but are not limited to (in alphabetical order) AdvancedMD, athenahealth Inc., Cerner Corporation, Change Healthcare, CPSI (Computer Programs and Systems Inc.), CureMD Healthcare, eClinicalWorks, Enli Health Intelligence, Epic Systems Corporation, Evolent Health, GE Healthcare, Greenway Medical Technologies, Harris Healthcare, Healthagen, Health Catalyst, Homecare Homebase (part of Hearst Health network), IBM Watson Health, IQVIA, Kareo, MEDHOST, Inc., Meditech (Medical Information Technology, Inc.), Navicure/Zirmed, NaviHealth (a Cardinal Health company), nThrive, Optum, Philips Wellcentive, Premier Inc., Quadramed, Quality Systems, Inc., Roper Industries, T-System, The TriZetto Group, Inc. (a division of Cognizant Technology Solutions, Inc.) and Wellsoft Corporation.





  

Overall company Market Share Q4 2024

Overall company, revenue fell by -3.72 % and company lost market share, to approximately 0.09 %.




<<  More on MDRX Market Share.
 
*Market share is calculated based on total revenue.

  News about Veradigm Inc Contracts

Veradigm Faces Delay in Financial Restatement Process as Competitor Allscripts Reports Revenue Decrease

February 27, 2024
Veradigm Inc. (NASDAQ: MDRX), a prominent provider of healthcare data and technology solutions, recently announced a delay in filing its annual and quarterly reports. While the company strives to address its financial restatement process, its competitor, Allscripts Healthcare Solutions Inc, reported a significant decrease in revenue during the third quarter of 2022, in contrast to its competitors revenue growth.Veradigm s Financial Restatement Process:Veradigm Inc. provided an update stating that it does not anticipate filing its Annual Report on Form 10-K for the year ended December 31, 2022, and its Quarterly Reports on Form 10-Q for the quarters ending March 31, 2023, June 30, 2023, and September 30, 202...

Veradigm Inc. Faces Class Action Lawsuit: Shining Light on Alleged Accounting Fraud

January 20, 2024
Veradigm Inc. (NASDAQ: MDRX), a prominent player in the healthcare solutions industry, is currently facing a class action lawsuit that alleges accounting fraud. This article explores the key details surrounding the lawsuit and provides an analysis of its potential impact on Veradigm and its investors. Background: Hagens Berman, a respected law firm, has encouraged Veradigm investors who have suffered substantial losses to submit their claims before the January 22nd deadline. The lawsuit claims that Veradigm engaged in fraudulent accounting practices, which led to significant financial losses for investors. As such, it is crucial to analyze the context in which this lawsuit is being filed and its potential im...

Veradigm's Dynamic Leadership Transforms Healthcare Landscape Amidst Industry Challenges

January 10, 2024
Veradigm Inc., a renowned provider of healthcare data and technology solutions, recently unveiled its reinvigorated leadership team. Dr. Shih-Yin Ho, serving as the Interim CEO, and Lee Westerfield, as the Interim CFO, presented Veradigm s vision, business strategies, and innovation plans at the J.P. Morgan Healthcare Conference. Additionally, they provided an updated fiscal 2023 financial outlook, shedding light on the company s potential growth trajectory. This article delves into Veradigm s recent developments and explores how they stack up against their competitors.Veradigm s Vision and Operational Focus:In their presentation, Dr. Ho and Mr. Westerfield discussed Veradigm s mission to revolutionize the h...

Veradigm Empowers Independent Healthcare Providers with AI-Driven Billing Services

December 11, 2023
Veradigm Enhances Independent Practice Financial Management with AI for Practice Fusion Billing Services
Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, has recently unveiled a new addition to its services, a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services. This enhanced feature aims to streamline the billing process and optimize financial management for independent healthcare providers.
The integration of AI technology into the Practice Fusion Billing Services offers a revolutionary way for healthcare providers to manage their billing processes. The conversational AI agent is designed to quickly address any queries ...





Publicly Traded Peers of Veradigm Inc




Aspen Technology inc
Share Performance



+32.28%
One Year



Aspen Technology inc
Profile

Aspen Technology Inc operates on a software-centric business model, offering advanced analytics and automation solutions to various industries including energy, chemicals, engineering, and pharma. The company primarily generates revenue through the sale of licenses, maintenance, and customer support services for their software products. By leveraging their expertise in process optimization and data analytics, Aspen Technology aims to help clients achieve operational excellence, improve efficiency, and maximize profitability.

More about Aspen Technology inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 16,821.433 mill. $ 1,140.149 mill. $ 6.131 mill.


Optimizerx Corp
Share Performance



-58.33%
One Year



Optimizerx Corp
Profile

Optimizerx Corp's business model revolves around providing a platform that connects pharmaceutical companies, healthcare providers, and patients. The company aims to enhance medication adherence and patient engagement by offering digital tools, including electronic vouchers, co-pay savings, and messaging services.

More about Optimizerx Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 141.831 mill. $ 98.654 mill. $ 4.601 mill.


Phreesia Inc
Share Performance



+14.03%
This Quarter



Phreesia Inc
Profile

Phreesia Inc operates on a software-as-a-service (SaaS) business model, offering a patient intake platform for healthcare organizations. They provide electronic patient registration, secure data collection, and customizable workflows to streamline the check-in process. Their revenue is generated through subscription fees paid by healthcare providers for utilizing their platform and services.

More about Phreesia Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 644.623 mill. $ 507.793 mill. $ 10.447 mill.


Premier Inc
Share Performance



-1.34%
30 Days



Premier Inc
Profile

is a leading healthcare improvement company

More about Premier Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,132.636 mill. $ 1,004.538 mill. $ -25.216 mill.


Rite Aid Corp
Share Performance



+4.56%
Over The Past 5 Days



Rite Aid Corp
Profile

Rite Aid Corp operates as a retail pharmacy chain, offering a range of healthcare products and services. Their business model revolves around providing prescription medications, over-the-counter drugs, personal care items, and general merchandise to customers through their physical store locations. Rite Aid also offers pharmacy benefit management services and operates walk-in clinics for basic medical services.

More about Rite Aid Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 35.855 mill. $ 23,475.490 mill. $ -1,593.910 mill.

16 more competitors available

Sign in to see all competitors

Sources: Veradigm Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Veradigm Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.